Cobran, et al v. Sarepta Therapeutics, Inc., et al
| DANIEL BARADARIAN, individually and on behalf of all others similarly situated and BIJESH AMIN |
| MARK A. COBRAN, individually and on behalf of all others similarly situated and STEVE FLEISCHMANN, individually and on behalf of all others similarly situated |
| SAREPTA THERAPEUTICS, INC., CHRIS GARABEDIAN, SANDY MAHATME and ED KAYE |
| BRIAN HEIDRICH and CORBAN GROUP |
| 15-2135 |
| September 30, 2015 |
| U.S. Court of Appeals, First Circuit |
| Securities/Commodities/Exchange |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Corban v. Sarepta Therapeutics, Inc.
|
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
